GLP-3 RT

GLP-3 is a novel investigational peptide that acts as a triple agonist of GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. By engaging all three incretin pathways, Reta has been studied for its potential to dramatically improve metabolic health by regulating blood glucose, reducing body weight, and enhancing energy expenditure. Early clinical research highlights its strong potential in obesity, type 2 diabetes, and cardiometabolic studies.

Key Benefits:

• Supports research on weight management and fat reduction through triple incretin action.
• Enhances glucose control and insulin sensitivity in metabolic studies.
• Promotes energy expenditure and improved metabolic flexibility.
• Explored for cardiovascular and liver health benefits in experimental models.

Purity Guaranteed

Every peptide we offer undergoes rigorous testing to ensure research-grade purity. Our claims are backed by regular in-house & third-party batch testing, guaranteeing the highest quality standards.

This product is for research purposes only. It is intended exclusively for in vitro testing and laboratory experiments. All information provided on this website is for educational purposes and is not intended for human or animal use. The introduction of this product into the body, whether by ingestion, injection, or any other means, is strictly prohibited by law. Only licensed and qualified professionals should handle this product. It is not a drug, food, or cosmetic and must not be mislabeled, misused, or marketed as such.